Live Breaking News & Updates on கேய்ட் பெர்மன்|Page 3

Stay updated with breaking news from கேய்ட் பெர்மன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Decision Diagnostics Corp.: DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit


(2)
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test results it has amassed demonstrating the technology s promise
LOS ANGELES, CA / ACCESSWIRE / December 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the designer and manufacturer of the proposed GenViro! Covid-19 :10 test kits, today announced it is proceeding with final testing of the GenViro! Covid-19 Saliva Swift Kit and will continue in its efforts to bring this valuable technology to market. Initially, the company will be releasing a series of test results collected from its Korean partner, from the detailed XPRIZE sample testing and as it becomes available, from its US-based testing, all of which will be submitted to the FDA for ....

Puerto Rico , United States , Russian Federation , Keith Berman , Pharma Tech Solutions Inc , Decision Diagnostics Corp , Decision Diagnostics , Pharma Tech Solutions , Swift Kit , Saliva Swift Kit , Monday December , Looking Statements , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் , ரஷ்ய கூட்டமைப்பு , கேய்ட் பெர்மன் , பார்மா தொழில்நுட்பம் தீர்வுகள் இன்க் , முடிவு பரிசோதனை கார்ப் , முடிவு பரிசோதனை , பார்மா தொழில்நுட்பம் தீர்வுகள் , ஸ்விஃப்ட் கிட் , உமிழ்நீர் ஸ்விஃப்ட் கிட் , திங்கட்கிழமை டிசம்பர் , பார்க்கிறது அறிக்கைகள் ,

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm


Home / Top News / SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm
PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) Kaskela Law LLC announces that it is investigating Decision Diagnostics Corp. (“Decision Diagnostics”) (OTC: DECN) on behalf of the company’s stockholders.
On December 17, 2020, the U.S. Securities and Exchange Commission (“SEC”) filed a complaint against Decision Diagnostics and its Chief Executive Officer (“CEO”), Keith Berman, in the U.S. District Court for the Southern District of New York. The complaint alleges that Decision Diagnostics and Berman seized upon the Covid-19 global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood te ....

New York , United States , Newtown Square , Keith Berman , D Seamus Kaskela , Exchange Commission , Decision Diagnostics Corp , Kaskela Law , Us District Court , Decision Diagnostics , Chief Executive Officer , Southern District , Decision Diagnostic , Seamus Kaskela , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதிய நகரம் சதுரம் , கேய்ட் பெர்மன் , ட சீமஸ் காஸ்கேல , பரிமாற்றம் தரகு , முடிவு பரிசோதனை கார்ப் , காஸ்கேல சட்டம் , எங்களுக்கு மாவட்டம் நீதிமன்றம் , முடிவு பரிசோதனை , தலைமை நிர்வாகி அதிகாரி , தெற்கு மாவட்டம் ,

DECN Comments on Recent Legal Filings by Federal Agencies – IT Business Net

CEO charged in alleged COVID-19 fraud scheme


CEO charged in alleged COVID-19 fraud scheme
MarketWatch
12/19/2020
Claudia Assis
© Thomson Reuters
A vial of the Pfizer vaccine against the coronavirus disease (COVID-19) used at The Reservoir nursing facility is shown in West Hartford, Connecticut, U.S., December 18, 2020. Stephen Dunn/Pool via REUTERS
The Justice Department said late Friday that a federal grand jury has indicted a California chief executive for allegedly concocting a scheme to defraud investors with false claims about a COVID-19 test.
Popular Searches
That led to millions of dollars in investors losses, the DOJ said. Keith Berman, 67, the CEO of Decision Diagnostics Inc. was charged with one count of securities fraud and one count of making false statements, the DOJ said. ....

West Hartford , United States , Keith Berman , Decision Diagnostics Inc , Drug Administration , Justice Department , Thomson Reuters , Decision Diagnostics , மேற்கு ஹார்ட்ஃபோர்ட் , ஒன்றுபட்டது மாநிலங்களில் , கேய்ட் பெர்மன் , முடிவு பரிசோதனை இன்க் , நீதி துறை , தாம்சன் ராய்ட்டர்ஸ் , முடிவு பரிசோதனை ,